Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Uncategorized
Page 10
Uncategorized
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I
atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics
atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants
Why The Future of The Psychedelic Industry Could Be In The...
Psychedelic Spotlight: MagicMed Industries
In Another Historic First for Psychedelics, The World’s First Psychedelic ETF...
Psychedelics Versus Cannabis: Exploring their Impact on Treating Mental Illness
Progressive Law Firm Zuber Lawler Is at Forefront of Modern Psychedelic...
SALT Talks: Psychedelics with Sa’ad Shah (Noetic Fund) & JR Rahn...
Feb 10: $SPOR +40.91%, $PSYC +35.42%, $MCUR +23.33%
Psychedelic Guides with Cody Shandraw of Ambria Capital
PsyCap Recap: 3 Key Takeaways From the Psygen Industries Presentation at...
Understanding the Strengths & Weaknesses of Different Patent Types
1
...
9
10
11
12
Page 10 of 12